Report Categories
View AllRecent Articles
View All
Is Tarsus Pharmaceuticals TARS stock failing to hold levels Tarsus Pharmaceuticals posts wider than expected EPS loss
VINP Vinci posts 49 percent Q4 2025 EPS miss with shares falling 063 percent in todays trade
EOG Resources Inc EOG Q1 2026 Earnings Preview Robust Growth Trajectory and High Beat Probability Amid Tight Energy Markets
YOUL Youlife core lifestyle service segment growth drives solid quarterly performance amid broader market headwinds